NEW YORK (GenomeWeb) – Avant Diagnostics said today that it has entered a securities purchase agreement through which it has raised gross proceeds of $650,000 and paid down a portion of the company's debt.
NEW YORK (GenomeWeb) – Avant Diagnostics said today that it has entered a securities purchase agreement through which it has raised gross proceeds of $650,000 and paid down a portion of the company's debt.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.